Table 2 Association of BCL6 protein expression with clinicopathological parameters from breast cancer patients
From: B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells
Parameter | n | BCL6 protein | |
|---|---|---|---|
| Â | Â | Positive, n(%) | Pvalue |
Age (years) | Â | ||
≤ 35 | 6 | 2 (33.3) | 0.253 |
35-55 | 84 | 31 (36.9) | Â |
> 55 | 37 | 8 (21.6) | Â |
Tumor size (cm) | Â | ||
≤ 2 | 44 | 7 (15.9) | 0.004 |
>2 | 83 | 34 (41.0) | Â |
Lymph node metastasis | Â | ||
No | 58 | 13 (22.4) | 0.029 |
Yes | 69 | 28 (40.6) | Â |
Grade | Â | ||
I | 28 | 4 (14.3) | 0.003 |
II | 75 | 23 (30.7) | Â |
III | 24 | 14 (58.3) | Â |
Stage | Â | Â | Â |
I | 28 | 3 (10.7) | 0.006 |
II - III | 99 | 38 (38.4) | Â |
Estrogen receptor | Â | Â | Â |
Negative | 56 | 22 (39.3) | 0.134 |
Positive | 71 | 19 (26.8) | Â |
Progesterone receptor | Â | ||
Negative | 64 | 22 (34.4) | 0.611 |
Positive | 63 | 19 (30.2) | Â |
c-erbB-2 | Â | ||
low | 93 | 32 (34.4) | 0.397 |
high | 34 | 9 (26.5) | Â |
Ki67 | Â | Â | Â |
≤50% | 50 | 8 (16.0) | 0.002 |
>50% | 77 | 33 (42.9) | Â |